Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0000899243-19-002708

Options or other derivatives

  • Director acquired 986,842 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MAGRAB E. BRENDAN Director 2019-02-03 Grant or award · Common Stock Options +986,842 986,842 D
Loading xslF345X03/doc4.xml…